Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 2.38M | 2.24M | −148.8K (−6.2%) |
| Value | $11.4M | $7.67M | −$3.78M (−33.0%) |
New holders (9)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 98,046 | $336.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 25,125 | $86.0K | 0.00% |
| Quantum Private Wealth, LLC | 22,500 | $77.0K | 0.03% |
| Northern Trust Corp | 15,221 | $52.0K | 0.00% |
| Engineers Gate Manager LP | 11,790 | $40.0K | 0.00% |
| UBS Group AG | 11,385 | $39.0K | 0.00% |
| XTX Topco Ltd | 10,537 | $36.0K | 0.02% |
| BlackRock Inc. | 464 | $2.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 643 | $2.00K | 0.00% |
Sold out (4)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Altium Capital Management LP | 271,846 | $1.30M |
| Two Sigma Investments, LP | 25,715 | $123.0K |
| National Asset Management, Inc. | 18,600 | $90.0K |
| Royal Bank of Canada | 100 | $0 |